Post Profile






Cancer mutation gains ground as test for immunotherapy drugs

MADRID (Reuters) - Scientists are stepping up the hunt for better diagnostic tests to predict if cancer patients will benefit from costly modern immunotherapy drugs, which are transforming cancer care but remain a hit-and-miss affai...
read more

share

Related Posts


Testing for BRAF Genetic Mutation Beneficial Only in Aggressive Thyroid Cancers

Health : Newswise Medical News

Late stage thyroid cancer patients with aggressive disease may benefit from a genetic test, but experts caution that use of this test in early stage patients is inappropriate because it is unlikely to lead to better outcomes, accord...

Merck's immunotherapy, chemo mix shows extended lung cancer gains

Health : Reuters: Health

MADRID (Reuters) - Giving Merck & Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clini...

Scientists find new biomarker to guide cancer immunotherapy

Health : Reuters: Health

LONDON (Reuters) - Scientists said on Monday they had pinpointed a particular type of immune system cell that could predict more precisely if cancer patients are likely to respond to modern immunotherapy medicines.

FDA Approves New Lung Cancer Diagnostic "Cobas EGFR Mutation Test"

Health : Medical News Today

The U.S. Food and Drug Administration (FDA) has approved the cobas EGFR Mutation Test, a companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved companion diagnostic that detects epidermal growth...

Roche blood test could help 'personalize' cancer immunotherapy

Health : Reuters: Health

MADRID (Reuters) - A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunothe...

Comments


Copyright © 2016 Regator, LLC